Kestra Medical Technologies Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
9.0%projected annual EPS growth
Analyst Coverage
7analysts covering
FY Revenue (est.)
$137.1Mnext fiscal year
FY EPS (est.)
-$2.31next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue Growth Quarterly5,300.0%
Gross Margin Expansion Quarterly5,060.0%
Payer Contract Coverage Annually70.0
Watch Items
- Market Share Capture from Zoll Medical
- Reimbursement and Payer Coverage
Research as of 20 Jun 2026